PU¶PubMed·Journal article·Research (general)·3d agoTeprotumumab for dysthyroid optic neuropathy: a systematic review and pooled analysis of 81 eyes evaluating outcomes, safety, and durabilityTeprotumumab has a known side-effect profile that includes hearing-related adverse events (such as sensorineural hearing loss and tinnitus), so audiologists may encounter patients on this drug who need hearing monitoring.